新冠新抗体紧急获批,14位北京患者已接受治疗 - 2021年11月05日

A new neutralizing antibody treatment has been used on 14 COVID-19 patients in Beijing, according to renowned biophysical chemist Xie Xiaoliang, also known as Sunny Xie.

It is widely believed that DXP-593 and DXP-604 are two major SARS-CoV-2 (the virus that causes COVID-19) neutralizing antibody drug candidates. Recently, Xie's lab at Peking University "discovered something we didn't know."

"DXP-604 is actually really good in a special way," the winner of the 2015 Albany Prize in Medicine told the "WLA Panel Session: Reflections on the Pandemic and Public Health."